Blinded evaluation of reverse transcriptase-polymerase chain reaction prostate-specific antigen peripheral blood assay for molecular staging of prostate cancer.

[1]  R. Figlin,et al.  Quantitative Polymerase Chain Reaction Does not Improve Preoperative Prostate Cancer Staging: A Clinicopathological Molecular Analysis of 121 Patients , 1998 .

[2]  M. Banerjee,et al.  Presence of circulating prostate cells in the bone marrow of patients undergoing radical prostatectomy is predictive of disease-free survival. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  J. Chmiel,et al.  Prostate specific antigen reverse transcriptase-polymerase chain reaction assay in preoperative staging of prostate cancer. , 1997, The Journal of urology.

[4]  P. Unger,et al.  Prospective analysis of prostate-specific markers in pelvic lymph nodes of patients with high-risk prostate cancer. , 1997, Journal of the National Cancer Institute.

[5]  I. Sardi,et al.  The use of RT–”nested” PCR of prostate specific antigen to detect hematogenous neoplastic cells in patients with prostate adenocarcinoma , 1997, Journal of Molecular Medicine.

[6]  D. Tindall,et al.  Detection of circulating prostate cells by reverse transcriptase-polymerase chain reaction of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) messages. , 1997, Urology.

[7]  G. Raj,et al.  Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer. , 1997, The Journal of urology.

[8]  S. Chevillard,et al.  Positive prostate-specific antigen circulating cells detected by reverse transcriptase-polymerase chain reaction does not imply the presence of prostatic micrometastases. , 1997, Urology.

[9]  P. Kantoff,et al.  Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral blood of patients with metastatic androgen-independent prostatic carcinoma. , 1997, Urology.

[10]  K. Pantel,et al.  Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  W. Ellis,et al.  Early tumor cell dissemination in patients with clinically localized carcinoma of the prostate. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[12]  S. Loening,et al.  Increased analytical sensitivity of RT‐PCR of PSA mRNA decreases diagnostic specificity of detection of prostatic cells in blood , 1997, International journal of cancer.

[13]  J. Moul,et al.  Prostate cancer: diagnosis, treatment, and experience at one tertiary-care military medical center, 1989 and 1994. , 1996, Military medicine.

[14]  M. Benson,et al.  Molecular staging of genitourinary malignancies. , 1996, Urology.

[15]  M. Benson,et al.  Preoperative reverse transcriptase polymerase chain reaction for prostate specific antigen predicts treatment failure following radical prostatectomy. , 1996, The Journal of urology.

[16]  W. Gerald,et al.  Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  J. Oesterling,et al.  Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era. , 1995, Urology.

[18]  M. Benson,et al.  Enhanced reverse transcriptase‐polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer , 1995, Cancer.

[19]  R. Moreland,et al.  A rapid and simple method for the detection of prostate-specific antigen mRNA in archival tissue specimens using a reverse transcription-polymerase chain reaction assay. , 1995, Urology.

[20]  A. Deblasio,et al.  Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. , 1994, Cancer research.

[21]  V. Rangnekar,et al.  Identification of bone marrow micrometastases in patients with prostate cancer , 1994, Cancer.

[22]  J. Oesterling,et al.  The clinical usefulness of prostate specific antigen: update 1994. , 1994, The Journal of urology.

[23]  D. Grignon,et al.  Allelic loss in locally metastatic, multisampled prostate cancer. , 1994, Cancer research.

[24]  M. Benson,et al.  Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. , 1994, Urology.

[25]  T. Deguchi,et al.  Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction. , 1993, Cancer research.

[26]  Dale McLerran,et al.  An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. The Prostate Patient Outcomes Research Team. , 1993, JAMA.

[27]  J H Wasson,et al.  A structured literature review of treatment for localized prostate cancer. Prostate Disease Patient Outcome Research Team. , 1993, Archives of family medicine.

[28]  C. Croce,et al.  Detection of hematogenous micrometastasis in patients with prostate cancer. , 1992, Cancer research.

[29]  P. Vihko,et al.  cDNA coding for the entire human prostate specific antigen shows high homologies to the human tissue kallikrein genes. , 1989, Biochemical and biophysical research communications.

[30]  S. Smith,et al.  Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[31]  P. Wingo,et al.  Cancer statistics, 1997 , 1997, CA: a cancer journal for clinicians.

[32]  M. Toublanc,et al.  Value of the preoperative detection of prostate-specific-antigen-positive circulating cells by nested RT-PCR in patients submitted to radical prostatectomy. , 1997, European urology.

[33]  T. Visakorpi,et al.  New prognostic factors in prostatic carcinoma. , 1993, European urology.

[34]  F. Hofstädter.  Grading of prostate carcinoma , 1993 .